Diversity outcomes

The BTP has an exemplary track record in the recruitment and retention of underrepresented minorities. NIGMS has provided a data set for comparison in this regard, “Examples of NIGMS-Funded NRSA Training Programs with Notable Records of Diversity Recruitment and
Retention”. In that document, it is stated that “On average, NIGMS T32-funded programs support nearly 12 percent URM.” Relatively detailed data is provided for multiple individual years in that document for 19 T32 programs, and indeed for this data set of notable programs the URM percentage is 16.3%, above the stated average across all programs of 12%. For the trailing six years (program years 19-24), the NIGMS/MIT BTP has had a URM percentage of 25.4% (for the individual years 3/18, 5/19, 6/20, 6/18, 4/19, and 5/20). A scatter plot of URM
trainees vs. total trainees is shown in the figure at right to provide a more detailed representation of both MIT’s performance and that of the comparison set. Relative to this basis set of T32 programs chosen by NIGMS as notable in their success, the MIT BTP can
certainly be viewed to have accomplished satisfactory performance in the recruitment and retention of URM trainees for each of the program years 19-24.


The MIT BTP would like to highlight the following two BTP Aluma:

Carlos Bosques
Director at Momenta Pharmaceuticals

Professor Hector Hernandez
Assistant Professor of Chemical Engineering at Masdar Institute of Science and Technology

There are currently 15% URM students in the BTP Program

Career placement of those students who have graduated

• Assistant Professor of Chemical Engineering, Masdar Institute of Science and Technology
• President & Cofounder, Energy Experts
• Development Manager, PayPal
• CSO, AuxoCell Laboratories
• Staff Scientist, Thermo Fisher Scientific
• Life Sciences Strategic Advisor and Principal, L.E.K Consulting
• ‪Assistant Professor, Yale University‬\‬‬‬
• Consultant. Boston Consulting Group Inc.
• ‪Assistant Professor, Yale University‬‬‬‬
• Chief Quality Engineer, US Army
• Process Development Engineer III, Regeneron Pharmaceuticals
• Director of Product Management, Doximity
• Assoc. Consultant, Clarion Healthcare
• Assistant Director for Biological Innovation at the White House Office of Science and Technology Policy
• PDOC Assoc., MIT
• Scientist I, Bristol-Myers Squibb
• Quality Improvement Manager, Abarca Health LLC
• PDOC Medical Research Council, Cambridge, UK.